Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers
Clinical trial NCT02059291 · COMPLETED
Trial details
- NCT number
- NCT02059291
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-27
- Primary completion
- 2017-07-04
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.